Ondas (ONDS) Stock Climbs Following Strategic Business Presentation
In the most recent session, Ondas Holdings Inc. (NASDAQ: ONDS) shares increased 9.24%, finishing at $2.01. A successful virtual Investor Day event on Wednesday, when the firm presented encouraging preliminary financial data and explained its strategic goal through its Ondas Autonomous Systems (OAS) segment, was the driving force behind the stock’s upward trend. The company’s […]
Thumzup Media (TZUP) Stock Rose Sharply After Funding News
The shares of Thumzup Media Corporation (NASDAQ: TZUP) closed at $12.36 on Tuesday after rising 21.18% during the trading session. Following the company’s statement that it had successfully completed a registered direct offering, there was a significant increase. Preferred Financial Use and Stock Structure At a price of $60 per share, 108,333 shares of Series […]
FDA Recognition Triggers Major Surge In Mustang Bio (MBIO) Stock
The shares of Mustang Bio, Inc. (NASDAQ: MBIO) surged 180.67% on Monday, closing at $3.34, following the announcement of a major regulatory milestone. The increase followed the announcement that the U.S. Food and Drug Administration (FDA) has designated MB-101, MBIO’s investigational IL13Ra2-targeted CAR T-cell treatment, as an Orphan Drug to treat glioblastoma (GBM) and recurrent […]
Eyenovia (EYEN) Rebrands As Hyperion DeFi (HYPD), Sparks Investor Enthusiasm
Eyenovia, Inc. (NASDAQ: EYEN) shares surged dramatically on Wednesday, climbing 49.81% to close at $15.82. The significant market rally coincided with the company’s announcement of a complete rebranding initiative and corporate name change to Hyperion DeFi, Inc.. As of July 3, 2025, the company’s stock now trades under the new ticker symbol “HYPD” on the […]
Ramaco Resources (METC) Rallies On Upcoming Brook Mine Event
Ramaco Resources, Inc. (NASDAQ: METC) shares were on a significant boost, climbing 19.66% to reach $11.94 as of the last in the current trading session. The sharp rise in investor enthusiasm follows the announcement of a landmark event. Project Milestone Ramaco Resources and its subsidiary, Ramaco Rare Earth, LLC, are set to host a ribbon […]
Artelo Biosciences (ARTL) Stock Soars After Positive Preclinical Results
Monday saw a spectacular increase in the share price of Artelo Biosciences, Inc. (NASDAQ: ARTL), which shot up 95.72% to close at $13.27. The dramatic increase followed positive findings from a first-in-human clinical trial assessing ART26.12, a potential treatment candidate with a distinct mode of action that targets chronic pain. Positive Findings Artelo’s Phase 1 […]
Aeluma (ALMU) Sees Surge After Being Added to Russell 3000 Index
On Wednesday, Aeluma, Inc. (NASDAQ: ALMU) saw a robust surge, with its stock closing at $17.04 after rising 21.80%. As part of the 2025 Russell index reconstruction process, the news of Aeluma’s participation in the Russell 3000 Index, which will take effect after the U.S. market opens on June 30, was followed by the steep […]
Skye Bioscience (SKYE) Stock Climbs Sharply Following Promising Drug Presentation
As of Tuesday’s market close, shares of Skye Bioscience, Inc. (NASDAQ: SKYE) had jumped 18.81% to $3.41, driven by a slew of positive developments on its main anti-obesity candidate, nimacimab. The company’s involvement in important scientific and investor gatherings, such as the American Diabetes Association’s (ADA) 85th Scientific Sessions, which took place in Chicago from […]
Citius Oncology (CTOR) Advances Commercial Shift With A Launch Update
After a significant development update, shares of Citius Oncology, Inc. (NASDAQ: CTOR) jumped 20.50% to $1.88 as of the most recent check. LYMPHIR, an immunotherapy licensed by the FDA to treat relapsed or refractory cutaneous T-cell lymphoma (CTCL), is nearly ready for commercialization. The announcement marks a major milestone in Citius’s transformation from a development-stage […]
Sharps Technology (STSS) Moves Forward With Key Supply Agreement
Sharps Technology, Inc. (NASDAQ: STSS) saw its shares climb by 9.58% to $5.49 in recent trading following the announcement of its second shipment execution under a previously disclosed $50 million SoloGard syringe sales agreement. The development signifies a major step in STSS’ transition toward full-scale commercial operations and revenue generation. Strategic Manufacturing Enhancements Underway As […]